255 related articles for article (PubMed ID: 16929547)
1. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.
Ofori B; Oraichi D; Blais L; Rey E; Bérard A
Birth Defects Res B Dev Reprod Toxicol; 2006 Aug; 77(4):268-79. PubMed ID: 16929547
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
[TBL] [Abstract][Full Text] [Related]
3. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
[TBL] [Abstract][Full Text] [Related]
4. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects.
Cleves MA; Savell VH; Raj S; Zhao W; Correa A; Werler MM; Hobbs CA;
Birth Defects Res A Clin Mol Teratol; 2004 Mar; 70(3):107-13. PubMed ID: 15039924
[TBL] [Abstract][Full Text] [Related]
5. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403
[TBL] [Abstract][Full Text] [Related]
7. Maternal severe migraine and risk of congenital limb deficiencies.
Bánhidy F; Acs N; Horváth-Puhó E; Czeizel AE
Birth Defects Res A Clin Mol Teratol; 2006 Aug; 76(8):592-601. PubMed ID: 16955495
[TBL] [Abstract][Full Text] [Related]
8. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
[TBL] [Abstract][Full Text] [Related]
9. Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies.
Abe K; Honein MA; Moore CA
Birth Defects Res A Clin Mol Teratol; 2003 Nov; 67(11):911-8. PubMed ID: 14745928
[TBL] [Abstract][Full Text] [Related]
10. Maternal asthma, asthma medication use, and the risk of congenital heart defects.
Lin S; Herdt-Losavio M; Gensburg L; Marshall E; Druschel C
Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):161-8. PubMed ID: 19067406
[TBL] [Abstract][Full Text] [Related]
11. Prescriptions filled during pregnancy for drugs with the potential of fetal harm.
Kulaga S; Zargarzadeh AH; Bérard A
BJOG; 2009 Dec; 116(13):1788-95. PubMed ID: 19832828
[TBL] [Abstract][Full Text] [Related]
12. A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy.
Czeizel AE; Rockenbauer M; Olsen J; Sørensen HT
Int J Tuberc Lung Dis; 2001 Jun; 5(6):564-8. PubMed ID: 11409585
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs and the risk of psychosis.
Laan W; Selten JP; Grobbee DE; Smeets H; Kahn RS; Burger H
Eur Neuropsychopharmacol; 2007 Mar; 17(4):309-11. PubMed ID: 17097858
[TBL] [Abstract][Full Text] [Related]
14. Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis.
Popat RA; Tanner CM; van den Eeden SK; Bernstein AL; Bloch DA; Leimpeter A; McGuire V; Nelson LM
Amyotroph Lateral Scler; 2007 Jun; 8(3):157-63. PubMed ID: 17538777
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy.
Gidai J; Acs N; Bánhidy F; Czeizel AE
Toxicol Ind Health; 2008; 24(1-2):53-60. PubMed ID: 18818181
[TBL] [Abstract][Full Text] [Related]
16. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
17. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis.
Schneider V; Lévesque LE; Zhang B; Hutchinson T; Brophy JM
Am J Epidemiol; 2006 Nov; 164(9):881-9. PubMed ID: 17005625
[TBL] [Abstract][Full Text] [Related]
18. Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes.
Bérard A; Kori S
Headache; 2012; 52(7):1085-93. PubMed ID: 22612391
[TBL] [Abstract][Full Text] [Related]
19. Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis.
Singh G; Wu O; Langhorne P; Madhok R
Arthritis Res Ther; 2006; 8(5):R153. PubMed ID: 16995929
[TBL] [Abstract][Full Text] [Related]
20. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations.
Queisser-Luft A; Eggers I; Stolz G; Kieninger-Baum D; Schlaefer K
Am J Med Genet; 1996 May; 63(1):268-76. PubMed ID: 8723120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
